The Use of High-Content Screening for the Discovery and Characterization of Compounds That Modulate Mitotic Index and Cell Cycle Progression by Differing Mechanisms of Action

2006 ◽  
Vol 4 (2) ◽  
pp. 153-163 ◽  
Author(s):  
Amy Barabasz ◽  
Briana Foley ◽  
James C. Otto ◽  
Anisa Scott ◽  
John Rice
2017 ◽  
Vol 22 (4) ◽  
pp. 387-398
Author(s):  
Nina Berges ◽  
Katharina Arens ◽  
Verena Kreusch ◽  
Rainer Fischer ◽  
Stefano Di Fiore

Microtubule targeting agents (MTAs) are used for the treatment of cancer. Novel MTAs could provide additional and beneficial therapeutic options. To improve the sensitivity and throughput of standard immunofluorescence assays for the characterization of MTAs, we used SNAP-tag technology to produce recombinant tubulin monomers. To visualize microtubule filaments, A549 cells transfected with SNAP-tubulin were stained with a membrane-permeable, SNAP-reactive dye. The treatment of SNAP-tubulin cells with stabilizing MTAs such as paclitaxel resulted in the formation of coarsely structured microtubule filaments, whereas depolymerizing MTAs such as nocodazole resulted in diffuse staining patterns in which the tubulin filaments were no longer distinguishable. By combining these components with automated microscopy and image analysis algorithms, we established a robust high-content screening assay for MTAs with a Z′ factor of 0.7. Proof of principle was achieved by testing a panel of 10 substances, allowing us to identify MTAs and to distinguish between stabilizing and destabilizing modes of action. By extending the treatment of the cells from 2 to 20 h, our assay also detected abnormalities in cell cycle progression and in the formation of microtubule spindles, providing additional readouts for the discovery of new MTAs and facilitating their early identification during drug-screening campaigns.


2014 ◽  
Author(s):  
Gabriel Pineda ◽  
Florence Lambert-Fliszar ◽  
Gennarina L. Riso ◽  
Kathleen M. Kane ◽  
Catriona Jamieson

2014 ◽  
Vol 2014 ◽  
pp. 1-27 ◽  
Author(s):  
William P. Tansey

The MYC family of proteins is a group of basic-helix-loop-helix-leucine zipper transcription factors that feature prominently in cancer. Overexpression of MYC is observed in the vast majority of human malignancies and promotes an extraordinary set of changes that impact cell proliferation, growth, metabolism, DNA replication, cell cycle progression, cell adhesion, differentiation, and metastasis. The purpose of this review is to introduce the reader to the mammalian family of MYC proteins, highlight important functional properties that endow them with their potent oncogenic potential, describe their mechanisms of action and of deregulation in cancer cells, and discuss efforts to target the unique properties of MYC, and of MYC-driven tumors, to treat cancer.


2019 ◽  
Vol 116 (3) ◽  
pp. 24a
Author(s):  
Rachel Cinco ◽  
Per Niklas Hedde ◽  
Leonel Malacrida ◽  
Michelle A. Digman ◽  
Enrico Gratton

Cell Cycle ◽  
2009 ◽  
Vol 8 (18) ◽  
pp. 3043-3054 ◽  
Author(s):  
Séverine Cruet-Hennequart ◽  
Sangamitra Villalan ◽  
Agnieszka Kaczmarczyk ◽  
Elaine O’Meara ◽  
Anna M. Sokol ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document